Related Experiment Video
Updated: Jan 11, 2026

A Mouse Model to Investigate the Role of Cancer-Associated Fibroblasts in Tumor Growth
Published on: December 22, 2020
Fibroblast activation protein (FAP)-mediated promotion of metastasis via the FN1-TGFβ axis and immune suppression in
Mario Udinotti1, Udo Siebolts1,2, Marcus Bauer1
1Institute of Pathology, Martin Luther University Halle-Wittenberg, Halle, Germany.
Background:
Treatment options of aggressive thyroid carcinoma (TC) is limited due to its aggressiveness. Therefore, increased knowledge of the role of tumor intrinsic immune escape mechanisms and the microenvironment contributing to metastases formation is essential to improve the patients' outcome. These include extracellular matrix (ECM) components, cancer-associated fibroblasts (CAFs) and the expression of the fibroblast activation protein (FAP) known to be involved in immune evasion, disease progression and a worse prognosis of thyroid carcinoma (TC) patients.
Methods:
The Cancer Genome Atlas (TCGA) and Human Protein Atlas datasets of TC specimens as well as tissue microarrays (TMA) consisting of 187 TC samples were analyzed for marker expression and immune cell infiltration. TC cell lines treated with recombinant FAP, a FAP inhibitor, transfected with siRNA-FAP plasmids and/or co-cultured with CAFs were subjected to qPCR, Western blot analyses and flow cytometry, cell supernatants to ELISA for cytokine secretion, the TMAs to conventional immunohistochemistry (IHC).
Results:
Immunohistochemical staining and bioinformatics analyses of publicly available mRNA and protein expression profiles revealed a significant positive correlation between high FAP and fibronectin 1 (FN1) expression, metastatic parameters and CD8+ T cell infiltration in TC lesions compared to adjacent normal tissues. FAP directly cleaved FN1 associated with lower adhesion, a high invasive TC phenotype and inhibition of transforming growth factor beta (TGF-β). This is accompanied by reduced programmed death ligand 1 (PD-L1) and increased human leukocyte antigen (HLA)-ABC surface levels. Co-culture of TC cells with CAFs demonstrated an influence of FAP on the immune suppressive CAF subtypes.
Conclusions:
FAP-mediated alterations of ECM integrity, TC cells and CAFs underscore its potential as a powerful marker for tumor immunogenicity, immune infiltration and metastasis rendering it a promising therapeutic target for the treatment of aggressive ATC.
Insights
Fibroblast activation protein (FAP) promotes aggressive thyroid carcinoma (TC) by altering the tumor microenvironment and immune evasion. Targeting FAP may improve treatment outcomes for patients with advanced TC.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Aggressive thyroid carcinoma (TC) has limited treatment options due to its aggressiveness.
- Tumor-intrinsic immune escape mechanisms and the tumor microenvironment contribute to metastasis in TC.
- Extracellular matrix (ECM) components, cancer-associated fibroblasts (CAFs), and fibroblast activation protein (FAP) are implicated in immune evasion, disease progression, and poor prognosis in TC.
Purpose of the Study:
- To investigate the role of FAP in aggressive thyroid carcinoma.
- To explore the relationship between FAP, tumor microenvironment, and immune cell infiltration in TC.
- To assess FAP as a potential therapeutic target for aggressive TC.
Main Methods:
- Analysis of The Cancer Genome Atlas (TCGA) and Human Protein Atlas datasets for TC specimens.
- Examination of 187 TC samples using tissue microarrays (TMA) for marker expression and immune cell infiltration.
- In vitro studies involving TC cell lines treated with FAP modulators and co-cultured with CAFs, analyzed by qPCR, Western blot, flow cytometry, ELISA, and immunohistochemistry (IHC).
Main Results:
- High FAP and fibronectin 1 (FN1) expression correlated positively with metastatic parameters and CD8+ T cell infiltration in TC.
- FAP cleaved FN1, leading to reduced adhesion, increased invasion, and inhibition of transforming growth factor beta (TGF-β).
- FAP influenced immune suppressive CAF subtypes, reduced PD-L1, and increased HLA-ABC surface levels.
Conclusions:
- FAP-mediated alterations in ECM, TC cells, and CAFs highlight its role in tumor immunogenicity, immune infiltration, and metastasis.
- FAP is a promising therapeutic target for aggressive thyroid carcinoma (ATC).
- FAP serves as a powerful marker for predicting immune infiltration and metastatic potential in TC.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Mitogens and the Cell Cycle
The Tumor Microenvironment
Intracellular Signaling Affects Focal Adhesions
Some...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Introduction to Fibroblasts

